Full results & analysis
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fentanyl for Cough Attenuation During Emergence From Anaesthesia
NCT01308320Phase 4
Key facts
- Status
- Completed
- Start
- Feb 2010
- Primary completion
- Jul 2010
- Countries
- 1
- Sponsor
- Yonsei University
- Modality
- Orthosteric Ligands
- Drugs
- fentanyl
- Conditions
- cough
01
Overview
Phase 4, randomised, double-blind trial of fentanyl in cough (4 arms), sponsored by Yonsei University. Primary endpoint: Cough suppression. Started Feb 2010; status: completed.
02
Design
4 arms- Study design
- RandomizedDouble-blind
saline
control group: saline
F1 group
fentanyl 1 mcg/kg
F1.5 group
fentanyl 1.5 mcg/kg
F2 group
fentanyl 2 mcg/kg
03
Who it enrols
Female patients aged 20-59 with ASA I-II undergoing elective thyroidectomy for thyroid neoplasm.
04
Endpoints
Primary
Cough suppression
Beyond the preview
Go deeper on NCT01308320.
Full results, competitive context and analysis are in the Gosset platform.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01308320.